{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T18:59:46Z","timestamp":1782500386289,"version":"3.54.5"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01967-7","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T08:47:03Z","timestamp":1765442823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of a high versus low number of negative lymph nodes removed with survival and recurrence-free survival after lymph node dissection in breast cancer: a systematic review and meta-analysis of observational studies"],"prefix":"10.1007","volume":"26","author":[{"given":"Mansour","family":"Bahardoust","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyal","family":"Yarahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Naseri","family":"Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mehdikakoienejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benyamin","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Goodarzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Tizmaghz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"issue":"10","key":"1967_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102569","volume":"14","author":"B Smolarz","year":"2022","unstructured":"Smolarz B, Nowak AZ, Romanowicz H. Breast cancer\u2014epidemiology, classification, pathogenesis and treatment (review of literature). Cancers (Basel). 2022;14(10):2569.","journal-title":"Cancers (Basel)"},{"key":"1967_CR2","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3389\/fonc.2020.00864","volume":"10","author":"S Nardin","year":"2020","unstructured":"Nardin S, Mora E, Varughese FM, D\u2019Avanzo F, Vachanaram AR, Rossi V, et al. Breast cancer survivorship, quality of life, and late toxicities. Front Oncol. 2020;10:864.","journal-title":"Front Oncol"},{"issue":"6","key":"1967_CR3","first-page":"524","volume":"72","author":"AN Giaquinto","year":"2022","unstructured":"Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524\u201341.","journal-title":"CA Cancer J Clin"},{"key":"1967_CR4","doi-asserted-by":"publisher","unstructured":"Bellanger M, Zeinomar N, Tehranifar P, Terry MB. Are Global Breast Cancer Incidence and Mortality Patterns Related to Country- Specific Economic Development and Prevention Strategies? J Glob Oncol. 2018 Jul;4:1-16.https:\/\/doi.org\/10.1200\/JGO.17.00207.","DOI":"10.1200\/JGO.17.00207"},{"issue":"4","key":"1967_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250370","volume":"16","author":"J Li","year":"2021","unstructured":"Li J, Zhou Z, Dong J, Fu Y, Li Y, Luan Z, et al. Predicting breast cancer 5-year survival using machine learning: a systematic review. PLoS One. 2021;16(4):e0250370.","journal-title":"PLoS One"},{"issue":"4","key":"1967_CR6","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41416-022-01845-z","volume":"127","author":"A Valachis","year":"2022","unstructured":"Valachis A, Carlqvist P, Ma Y, Szilcz M, Freilich J, Vertuani S, et al. Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study. Br J Cancer. 2022;127(4):720\u20135.","journal-title":"Br J Cancer"},{"issue":"5","key":"1967_CR7","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S1470-2045(21)00071-1","volume":"22","author":"BO Anderson","year":"2021","unstructured":"Anderson BO, Ilbawi AM, Fidarova E, Weiderpass E, Stevens L, Abdel-Wahab M, et al. The global breast cancer initiative: a strategic collaboration to strengthen health care for non-communicable diseases. Lancet Oncol. 2021;22(5):578\u201381.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1967_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-04316-2","volume":"12","author":"J-Y Hsu","year":"2022","unstructured":"Hsu J-Y, Chang C-J, Cheng J-S. Survival, treatment regimens and medical costs of women newly diagnosed with metastatic triple-negative breast cancer. Sci Rep. 2022;12(1):729.","journal-title":"Sci Rep"},{"key":"1967_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10549-020-06090-7","volume":"186","author":"M Al-Masri","year":"2021","unstructured":"Al-Masri M, Aljalabneh B, Al-Najjar H, Al-Shamaileh T. Effect of time to breast cancer surgery after neoadjuvant chemotherapy on survival outcomes. Breast Cancer Res Treat. 2021;186:7\u201313.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"1967_CR10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/jamaoncol.2015.4508","volume":"2","author":"RJ Bleicher","year":"2016","unstructured":"Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong Y-N, et al. Time to surgery and breast cancer survival in the united States. JAMA Oncol. 2016;2(3):330\u20139.","journal-title":"JAMA Oncol"},{"issue":"5","key":"1967_CR11","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1001\/jamasurg.2015.4539","volume":"151","author":"A Thomas","year":"2016","unstructured":"Thomas A, Khan SA, Chrischilles EA, Schroeder MC. Initial surgery and survival in stage IV breast cancer in the United States, 1988\u20132011. JAMA Surg. 2016;151(5):424\u201331.","journal-title":"JAMA Surg"},{"issue":"6","key":"1967_CR12","doi-asserted-by":"publisher","first-page":"e778","DOI":"10.1016\/j.clbc.2020.06.002","volume":"20","author":"J Wang","year":"2020","unstructured":"Wang J, Chen L, Nie Y, Wu W, Yao Y. Nomogram for predicting the overall survival of patients with breast cancer with pathologic nodal status N3. Clin Breast Cancer. 2020;20(6):e778-85.","journal-title":"Clin Breast Cancer"},{"key":"1967_CR13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10549-020-05870-5","volume":"184","author":"Y Sun","year":"2020","unstructured":"Sun Y, Li Y, Wu J, Tian H, Liu H, Fang Y, et al. Nomograms for prediction of overall and cancer-specific survival in young breast cancer. Breast Cancer Res Treat. 2020;184:597\u2013613.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1967_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.29289\/2594539420190000437","volume":"29","author":"FB Makdissi","year":"2019","unstructured":"Makdissi FB, Leite FPM, Peres SV, Mendon\u00e7a DR, de Oliveira MM, Lopez RVM, et al. Breast cancer survival in a Brazilian cancer center: a cohort study of 5,095 patients. Mastology. 2019;29(1):37\u201346.","journal-title":"Mastology"},{"issue":"12","key":"1967_CR15","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2018.19.12.3489","volume":"19","author":"A Sarveazad","year":"2018","unstructured":"Sarveazad A, Babahajian A, Shamseddin J, Bahardoust M. 5-year survival rates and prognostic factors in patients with synchronus and metachronus breast cancer from 2010 to 2015. Asian Pac J Cancer Prevention: APJCP. 2018;19(12):3489.","journal-title":"Asian Pac J Cancer Prevention: APJCP"},{"key":"1967_CR16","first-page":"33","volume-title":"Prognostic models: a methodological framework and review of models for breast cancer","author":"DG Altman","year":"2007","unstructured":"Altman DG. Prognostic models: a methodological framework and review of models for breast cancer. Breast Cancer: CRC; 2007. pp. 33\u201348."},{"key":"1967_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/BF00666054","volume":"30","author":"GM Clark","year":"1994","unstructured":"Clark GM. Do we really need prognostic factors for breast cancer? Breast Cancer Res Treat. 1994;30:117\u201326.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1967_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1061-z","volume":"15","author":"S-G Wu","year":"2015","unstructured":"Wu S-G, Sun J-Y, Zhou J, Li F-Y, Lin Q, Lin H-X, et al. Number of negative lymph nodes is associated with disease-free survival in patients with breast cancer. BMC Cancer. 2015;15(1):43.","journal-title":"BMC Cancer"},{"issue":"11","key":"1967_CR19","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1093\/annonc\/mdl169","volume":"17","author":"I Blancas","year":"2006","unstructured":"Blancas I, Garc\u00eda-Puche JL, Bermejo B, Hanrahan EO, Monteagudo C, Mart\u00ednez-Agull\u00f3 A, et al. Low number of examined lymph nodes in node-negative breast cancer patients is an adverse prognostic factor. Ann Oncol. 2006;17(11):1644\u20139.","journal-title":"Ann Oncol"},{"issue":"12","key":"1967_CR20","doi-asserted-by":"publisher","first-page":"7450","DOI":"10.21037\/tcr-20-2351","volume":"9","author":"H Wu","year":"2020","unstructured":"Wu H, Huang Y. Negative lymph node count is an independent prognostic factor for female patients with node positive breast cancer. Transl Cancer Res. 2020;9(12):7450\u20137.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"1967_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12893-023-02154-9","volume":"23","author":"M Bahardoust","year":"2023","unstructured":"Bahardoust M, Kheirabadi M, Donyadideh G, Khaleghian M, Haghmoradi M, Tizmaghz A. Effect of the number of negative lymph nodes removed on the survival and recurrence rate after gastrectomy in patients with gastric cancer: a multicenter retrospective cohort study. BMC Surg. 2023;23(1):246.","journal-title":"BMC Surg"},{"issue":"3","key":"1967_CR22","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1378\/chest.128.3.1545","volume":"128","author":"MS Ludwig","year":"2005","unstructured":"Ludwig MS, Goodman M, Miller DL, Johnstone PA. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. Chest. 2005;128(3):1545\u201350.","journal-title":"Chest"},{"issue":"12","key":"1967_CR23","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1002\/1097-0142(20010615)91:12<2258::AID-CNCR1256>3.0.CO;2-V","volume":"91","author":"PG Moorman","year":"2001","unstructured":"Moorman PG, Hamza A, Marks JR, Olson JA Jr. Prognostic significance of the number of lymph nodes examined in patients with lymph node-negative breast carcinoma. Cancer. 2001;91(12):2258\u201362.","journal-title":"Cancer"},{"issue":"6","key":"1967_CR24","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.21037\/jtd.2017.05.30","volume":"9","author":"J Yang","year":"2017","unstructured":"Yang J, Long Q, Li H, Lv Q, Tan Q, Yang X. The value of positive lymph nodes ratio combined with negative lymph node count in prediction of breast cancer survival. J Thorac Dis. 2017;9(6):1531.","journal-title":"J Thorac Dis"},{"key":"1967_CR25","doi-asserted-by":"publisher","first-page":"8445","DOI":"10.1007\/s13277-015-4640-3","volume":"37","author":"F Xin","year":"2016","unstructured":"Xin F, Yu Y, Yang Z-J, Hou L-K, Mao J-F, Xia L, et al. Number of negative lymph nodes as a prognostic factor for ypN0-N1 breast cancer patients undergoing neoadjuvant chemotherapy. Tumor Biol. 2016;37:8445\u201354.","journal-title":"Tumor Biol"},{"issue":"5","key":"1967_CR26","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1111\/brv.12721","volume":"96","author":"RE O\u2019Dea","year":"2021","unstructured":"O\u2019Dea RE, Lagisz M, Jennions MD, Koricheva J, Noble DW, Parker TH, et al. Preferred reporting items for systematic reviews and meta-analyses in ecology and evolutionary biology: a PRISMA extension. Biol Rev. 2021;96(5):1695\u2013722.","journal-title":"Biol Rev"},{"key":"1967_CR27","unstructured":"Wells G, Shea B, O\u2019connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa, ON, Canada, Ottawa Hospital Research Institute, 2012. 2020."},{"issue":"7","key":"1967_CR28","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1200\/JCO.2002.07.112","volume":"20","author":"L Weir","year":"2002","unstructured":"Weir L, Speers C, D\u2019yachkova Y, Olivotto I. Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer. J Clin Oncol. 2002;20(7):1793\u20139.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1967_CR29","first-page":"844","volume":"5","author":"S-G Wu","year":"2015","unstructured":"Wu S-G, Wang Y, Zhou J, Sun J-Y, Li F-Y, Lin H-X, et al. Number of negative lymph nodes should be considered for incorporation into staging for breast cancer. Am J Cancer Res. 2015;5(2):844.","journal-title":"Am J Cancer Res"},{"key":"1967_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-015-1061-z","volume":"15","author":"S-G Wu","year":"2015","unstructured":"Wu S-G, Sun J-Y, Zhou J, Li F-Y, Lin Q, Lin H-X, et al. Number of negative lymph nodes is associated with disease-free survival in patients with breast cancer. BMC Cancer. 2015;15:1\u20137.","journal-title":"BMC Cancer"},{"issue":"11","key":"1967_CR31","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1093\/annonc\/mdl169","volume":"17","author":"I Blancas","year":"2006","unstructured":"Blancas I, Garcia-Puche J, Bermejo B, Hanrahan E, Monteagudo C, Martinez-Agullo A, et al. Low number of examined lymph nodes in node-negative breast cancer patients is an adverse prognostic factor. Ann Oncol. 2006;17(11):1644\u20139.","journal-title":"Ann Oncol"},{"issue":"4","key":"1967_CR32","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/cncr.20830","volume":"103","author":"JK Salama","year":"2005","unstructured":"Salama JK, Heimann R, Lin F, Mehta N, Chmura SJ, Singh R, et al. Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance? Cancer. 2005;103(4):664\u201371.","journal-title":"Cancer"},{"issue":"4","key":"1967_CR33","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005998","volume":"96","author":"H Wang","year":"2017","unstructured":"Wang H, Zhang C, Kong L, Zhu H, Yu J. Better survival in PMRT of female breast cancer patients with >\u20095 negative lymph nodes: a population-based study. Medicine (Baltimore). 2017;96(4):e5998.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1967_CR34","first-page":"68","volume":"47","author":"Q-X Wang","year":"2017","unstructured":"Wang Q-X, Cai Y-F, Chen Y-Y, Zhang W, Jin W-X, Chen E-D, et al. Additional prognostic value of lymph node ratio (LNR) and number of negative lymph nodes (NLNs) in Chinese patients with triple negative breast cancer. Annals Clin Lab Sci. 2017;47(1):68\u201375.","journal-title":"Annals Clin Lab Sci"},{"key":"1967_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-014-0284-5","volume":"9","author":"S-G Wu","year":"2014","unstructured":"Wu S-G, Sun J-Y, Zhou J, Li F-Y, Zhou H, Lin Q, et al. Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy. Radiat Oncol. 2014;9:1\u20139.","journal-title":"Radiat Oncol"},{"issue":"1","key":"1967_CR36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<108::AID-CNCR15>3.0.CO;2-B","volume":"88","author":"RL Camp","year":"2000","unstructured":"Camp RL, Rimm EB, Rimm DL. A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome. Cancer. 2000;88(1):108\u201313.","journal-title":"Cancer"},{"issue":"12","key":"1967_CR37","doi-asserted-by":"publisher","first-page":"7450","DOI":"10.21037\/tcr-20-2351","volume":"9","author":"H Wu","year":"2020","unstructured":"Wu H, Huang Y. Negative lymph node count is an independent prognostic factor for female patients with node positive breast cancer. Transl Cancer Res. 2020;9(12):7450.","journal-title":"Transl Cancer Res"},{"key":"1967_CR38","doi-asserted-by":"crossref","unstructured":"Unger JM, Moseley A, Symington B, Chavez-MacGregor M, Ramsey SD, Hershman DL. Geographic Distribution and Survival Outcomes for Rural Patients With Cancer Treated in Clinical Trials. JAMA Netw Open. 2018 Aug 3;1(4):e181235.","DOI":"10.1001\/jamanetworkopen.2018.1235"},{"issue":"6","key":"1967_CR39","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/ajco.13958","volume":"19","author":"X Tao","year":"2023","unstructured":"Tao X, Li T, Gandomkar Z, Brennan PC, Reed WM. Incidence, mortality, survival, and disease burden of breast cancer in China compared to other developed countries. Asia-Pac J Clin Oncol. 2023;19(6):645\u201354.","journal-title":"Asia-Pac J Clin Oncol"},{"issue":"10","key":"1967_CR40","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1002\/cncr.35188","volume":"130","author":"K Sathishkumar","year":"2024","unstructured":"Sathishkumar K, Sankarapillai J, Mathew A, Nair RA, Gangane N, Khuraijam S, et al. Breast cancer survival in India across 11 geographic areas under the National cancer registry programme. Cancer. 2024;130(10):1816\u201325.","journal-title":"Cancer"},{"issue":"5","key":"1967_CR41","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/aje\/kwn369","volume":"169","author":"M Schootman","year":"2009","unstructured":"Schootman M, Jeffe DB, Lian M, Gillanders WE, Aft R. The role of poverty rate and racial distribution in the geographic clustering of breast cancer survival among older women: a geographic and multilevel analysis. Am J Epidemiol. 2009;169(5):554\u201361.","journal-title":"Am J Epidemiol"},{"issue":"7","key":"1967_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271319","volume":"17","author":"B Conti","year":"2022","unstructured":"Conti B, Bochaton A, Charreire H, Kitzis-Bonsang H, Despr\u00e8s C, Baffert S, et al. Influence of geographic access and socioeconomic characteristics on breast cancer outcomes: a systematic review. PLoS One. 2022;17(7):e0271319.","journal-title":"PLoS One"},{"issue":"7","key":"1967_CR43","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/jnci\/94.7.490","volume":"94","author":"CJ Bradley","year":"2002","unstructured":"Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94(7):490\u20136.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"1967_CR44","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/tbj.13250","volume":"25","author":"LA Riba","year":"2019","unstructured":"Riba LA, Gruner RA, Alapati A, James TA. Association between socioeconomic factors and outcomes in breast cancer. Breast J. 2019;25(3):488\u201392.","journal-title":"Breast J"},{"key":"1967_CR45","doi-asserted-by":"publisher","unstructured":"Chiyoda T, Sakurai M, Satoh T, Nagase S, Mikami M, Katabuchi H, Aoki D. Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis. J Gynecol Oncol. 2020 Sep;31(5):e67. https:\/\/doi.org\/10.3802\/jgo.2020.31.e67.","DOI":"10.3802\/jgo.2020.31.e67"},{"issue":"2","key":"1967_CR46","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/SLA.0000000000002824","volume":"269","author":"E Visser","year":"2019","unstructured":"Visser E, Markar SR, Ruurda JP, Hanna GB, van Hillegersberg R. Prognostic value of lymph node yield on overall survival in esophageal cancer patients: a systematic review and meta-analysis. Ann Surg. 2019;269(2):261\u20138.","journal-title":"Ann Surg"},{"issue":"2","key":"1967_CR47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1308\/rcsann.2016.0340","volume":"99","author":"M Elshaer","year":"2017","unstructured":"Elshaer M, Gravante G, Kosmin M, Riaz A, Al-Bahrani A. A systematic review of the prognostic value of lymph node ratio, number of positive nodes and total nodes examined in pancreatic ductal adenocarcinoma. Ann R Coll Surg Engl. 2017;99(2):101\u20136.","journal-title":"Ann R Coll Surg Engl"},{"issue":"11","key":"1967_CR48","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJMoa2412063","volume":"392","author":"T Reimer","year":"2025","unstructured":"Reimer T, Stachs A, Veselinovic K, K\u00fchn T, Heil J, Polata S, et al. Axillary surgery in breast cancer \u2014 primary results of the INSEMA trial. N Engl J Med. 2025;392(11):1051\u201364.","journal-title":"N Engl J Med"},{"key":"1967_CR49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.breast.2016.09.005","volume":"30","author":"MM Youssef","year":"2016","unstructured":"Youssef MM, Cameron D, Pucher PH, Olsen S, Ferguson D. The significance of Sentinel lymph node micrometastasis in breast cancer: comparing outcomes with and without axillary clearance. Breast. 2016;30:101\u20134.","journal-title":"Breast"},{"key":"1967_CR50","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10549-016-4015-5","volume":"161","author":"J Iqbal","year":"2017","unstructured":"Iqbal J, Ginsburg O, Giannakeas V, Rochon PA, Semple JL, Narod SA. The impact of nodal micrometastasis on mortality among women with early-stage breast cancer. Breast Cancer Res Treat. 2017;161:103\u201315.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"1967_CR51","first-page":"697","volume":"22","author":"V Vinh-Hung","year":"2003","unstructured":"Vinh-Hung V, Burzykowski T, Cserni G, Voordeckers M, Van De Steene J, Storme G. Functional form of the effect of the numbers of axillary nodes on survival in early breast cancer. Int J Oncol. 2003;22(3):697\u2013704.","journal-title":"Int J Oncol"},{"key":"1967_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7819-10-130","volume":"10","author":"KK Ovrebo","year":"2012","unstructured":"Ovrebo KK, Lie SA, Laerum OD, Svanes K, Viste A. Long-term survival from adenocarcinoma of the esophagus after transthoracic and transhiatal esophagectomy. World J Surg Oncol. 2012;10:1\u201310.","journal-title":"World J Surg Oncol"},{"issue":"5","key":"1967_CR53","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S0022-5223(99)70377-6","volume":"117","author":"JJ Nigro","year":"1999","unstructured":"Nigro JJ, DeMeester SR, Hagen JA, DeMeester TR, Peters JH, Kiyabu M, et al. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg. 1999;117(5):960\u20138.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"1967_CR54","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.athoracsur.2020.09.074","volume":"112","author":"L Depypere","year":"2021","unstructured":"Depypere L, De Hertogh G, Moons J, Provoost A-L, Lerut T, Sagaert X, et al. Importance of lymph node response after neoadjuvant chemoradiotherapy for esophageal adenocarcinoma. Ann Thorac Surg. 2021;112(6):1847\u201354.","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"1967_CR55","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1046\/j.1365-2168.2001.01746.x","volume":"88","author":"J Hulscher","year":"2001","unstructured":"Hulscher J, Van Sandick J, Offerhaus G, Tilanus H, Obertop H, Van Lanschot J. Prospective analysis of the diagnostic yield of extended en bloc resection for adenocarcinoma of the oesophagus or gastric cardia. Br J Surg. 2001;88(5):715\u20139.","journal-title":"Br J Surg"},{"key":"1967_CR56","doi-asserted-by":"crossref","unstructured":"Yoon HH, Khan M, Shi Q, Cassivi SD, Wu T-T, Quevedo JF, et al. editors. The prognostic value of clinical and pathologic factors in esophageal adenocarcinoma: a mayo cohort of 796 patients with extended follow-up after surgical resection. Mayo Clinic Proceedings; 2010: Elsevier.","DOI":"10.4065\/mcp.2010.0421"},{"issue":"6","key":"1967_CR57","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/cncr.23309","volume":"112","author":"AJ Greenstein","year":"2008","unstructured":"Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer. 2008;112(6):1239\u201346.","journal-title":"Cancer"},{"issue":"4","key":"1967_CR58","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1177\/1558944720963944","volume":"17","author":"AJ Forte","year":"2022","unstructured":"Forte AJ, Huayllani MT, Boczar D, Manrique OJ, Lu X, McLaughlin SA, et al. A systematic review of peripheral neuropathies in breast cancer\u2013related lymphedema. Hand. 2022;17(4):668\u201375.","journal-title":"Hand"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01967-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01967-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01967-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:19:49Z","timestamp":1767676789000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01967-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1967"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01967-7","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was registered with PROSPERO (CRD42024599907).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"88"}}